nodes	percent_of_prediction	percent_of_DWPC	metapath
Mefloquine—ADORA2A—Parkinson's disease	0.566	0.722	CbGaD
Mefloquine—CYP2D6—Parkinson's disease	0.127	0.162	CbGaD
Mefloquine—ABCB1—Parkinson's disease	0.0908	0.116	CbGaD
Mefloquine—HBA1—forelimb—Parkinson's disease	0.0121	0.132	CbGeAlD
Mefloquine—HBA2—forelimb—Parkinson's disease	0.0111	0.121	CbGeAlD
Mefloquine—HBA1—hindbrain—Parkinson's disease	0.00497	0.0541	CbGeAlD
Mefloquine—Flecainide—CYP2D6—Parkinson's disease	0.00318	1	CrCbGaD
Mefloquine—HBA2—embryo—Parkinson's disease	0.00286	0.0311	CbGeAlD
Mefloquine—HBA1—brainstem—Parkinson's disease	0.00285	0.031	CbGeAlD
Mefloquine—HBA1—forebrain—Parkinson's disease	0.00275	0.0299	CbGeAlD
Mefloquine—ADORA1—nerve—Parkinson's disease	0.00274	0.0298	CbGeAlD
Mefloquine—HBA2—forebrain—Parkinson's disease	0.00253	0.0275	CbGeAlD
Mefloquine—HBA1—cardiovascular system—Parkinson's disease	0.00233	0.0253	CbGeAlD
Mefloquine—HBA2—cardiovascular system—Parkinson's disease	0.00214	0.0232	CbGeAlD
Mefloquine—HBA1—spinal cord—Parkinson's disease	0.00177	0.0193	CbGeAlD
Mefloquine—HBA2—spinal cord—Parkinson's disease	0.00163	0.0177	CbGeAlD
Mefloquine—HBA1—head—Parkinson's disease	0.00157	0.0171	CbGeAlD
Mefloquine—HBA1—nervous system—Parkinson's disease	0.00149	0.0163	CbGeAlD
Mefloquine—HBA2—head—Parkinson's disease	0.00145	0.0157	CbGeAlD
Mefloquine—HBA1—central nervous system—Parkinson's disease	0.00144	0.0156	CbGeAlD
Mefloquine—HBA1—cerebellum—Parkinson's disease	0.00141	0.0153	CbGeAlD
Mefloquine—HBA2—nervous system—Parkinson's disease	0.00137	0.0149	CbGeAlD
Mefloquine—HBA2—central nervous system—Parkinson's disease	0.00132	0.0144	CbGeAlD
Mefloquine—ADORA2A—forebrain—Parkinson's disease	0.00131	0.0143	CbGeAlD
Mefloquine—HBA2—cerebellum—Parkinson's disease	0.00129	0.014	CbGeAlD
Mefloquine—HBA1—brain—Parkinson's disease	0.00114	0.0124	CbGeAlD
Mefloquine—ADORA1—forebrain—Parkinson's disease	0.00113	0.0124	CbGeAlD
Mefloquine—ADORA2A—cardiovascular system—Parkinson's disease	0.00111	0.0121	CbGeAlD
Mefloquine—HBA2—brain—Parkinson's disease	0.00105	0.0114	CbGeAlD
Mefloquine—ADORA1—cardiovascular system—Parkinson's disease	0.00096	0.0104	CbGeAlD
Mefloquine—ADORA2A—spinal cord—Parkinson's disease	0.000847	0.00922	CbGeAlD
Mefloquine—ADORA1—medulla oblongata—Parkinson's disease	0.00082	0.00893	CbGeAlD
Mefloquine—ACHE—medulla oblongata—Parkinson's disease	0.000815	0.00887	CbGeAlD
Mefloquine—CYP19A1—forebrain—Parkinson's disease	0.00077	0.00838	CbGeAlD
Mefloquine—ADORA2A—head—Parkinson's disease	0.000753	0.00819	CbGeAlD
Mefloquine—ADORA1—midbrain—Parkinson's disease	0.000749	0.00816	CbGeAlD
Mefloquine—ACHE—midbrain—Parkinson's disease	0.000745	0.00811	CbGeAlD
Mefloquine—ADORA1—spinal cord—Parkinson's disease	0.000731	0.00796	CbGeAlD
Mefloquine—ACHE—spinal cord—Parkinson's disease	0.000727	0.00791	CbGeAlD
Mefloquine—ADORA2A—nervous system—Parkinson's disease	0.000714	0.00777	CbGeAlD
Mefloquine—ADORA2A—central nervous system—Parkinson's disease	0.000687	0.00748	CbGeAlD
Mefloquine—ADORA2A—cerebellum—Parkinson's disease	0.000671	0.00731	CbGeAlD
Mefloquine—CYP2D6—hindbrain—Parkinson's disease	0.000664	0.00723	CbGeAlD
Mefloquine—ADORA1—head—Parkinson's disease	0.00065	0.00707	CbGeAlD
Mefloquine—ADORA1—nervous system—Parkinson's disease	0.000616	0.00671	CbGeAlD
Mefloquine—ADORA1—central nervous system—Parkinson's disease	0.000593	0.00646	CbGeAlD
Mefloquine—ADORA1—cerebellum—Parkinson's disease	0.00058	0.00631	CbGeAlD
Mefloquine—ACHE—cerebellum—Parkinson's disease	0.000576	0.00627	CbGeAlD
Mefloquine—BCHE—brainstem—Parkinson's disease	0.000574	0.00625	CbGeAlD
Mefloquine—BCHE—forebrain—Parkinson's disease	0.000554	0.00603	CbGeAlD
Mefloquine—ADORA2A—brain—Parkinson's disease	0.000545	0.00594	CbGeAlD
Mefloquine—ADORA1—brain—Parkinson's disease	0.000471	0.00513	CbGeAlD
Mefloquine—BCHE—cardiovascular system—Parkinson's disease	0.000469	0.0051	CbGeAlD
Mefloquine—ACHE—brain—Parkinson's disease	0.000468	0.00509	CbGeAlD
Mefloquine—CYP19A1—head—Parkinson's disease	0.000441	0.0048	CbGeAlD
Mefloquine—CYP19A1—nervous system—Parkinson's disease	0.000418	0.00455	CbGeAlD
Mefloquine—CYP19A1—central nervous system—Parkinson's disease	0.000402	0.00438	CbGeAlD
Mefloquine—BCHE—medulla oblongata—Parkinson's disease	0.000401	0.00436	CbGeAlD
Mefloquine—CYP2D6—brainstem—Parkinson's disease	0.000381	0.00414	CbGeAlD
Mefloquine—CYP2D6—forebrain—Parkinson's disease	0.000367	0.004	CbGeAlD
Mefloquine—BCHE—midbrain—Parkinson's disease	0.000366	0.00398	CbGeAlD
Mefloquine—BCHE—spinal cord—Parkinson's disease	0.000357	0.00389	CbGeAlD
Mefloquine—CYP19A1—brain—Parkinson's disease	0.000319	0.00348	CbGeAlD
Mefloquine—BCHE—head—Parkinson's disease	0.000317	0.00345	CbGeAlD
Mefloquine—BCHE—nervous system—Parkinson's disease	0.000301	0.00328	CbGeAlD
Mefloquine—ABCB1—embryo—Parkinson's disease	0.000299	0.00325	CbGeAlD
Mefloquine—BCHE—central nervous system—Parkinson's disease	0.00029	0.00315	CbGeAlD
Mefloquine—BCHE—cerebellum—Parkinson's disease	0.000283	0.00308	CbGeAlD
Mefloquine—ABCB1—forebrain—Parkinson's disease	0.000264	0.00288	CbGeAlD
Mefloquine—BCHE—brain—Parkinson's disease	0.00023	0.0025	CbGeAlD
Mefloquine—ABCB1—cardiovascular system—Parkinson's disease	0.000223	0.00243	CbGeAlD
Mefloquine—CYP2D6—head—Parkinson's disease	0.00021	0.00229	CbGeAlD
Mefloquine—CYP3A4—nervous system—Parkinson's disease	0.000203	0.00221	CbGeAlD
Mefloquine—CYP2D6—nervous system—Parkinson's disease	0.000199	0.00217	CbGeAlD
Mefloquine—CYP3A4—central nervous system—Parkinson's disease	0.000195	0.00212	CbGeAlD
Mefloquine—CYP2D6—central nervous system—Parkinson's disease	0.000192	0.00209	CbGeAlD
Mefloquine—ABCB1—medulla oblongata—Parkinson's disease	0.000191	0.00208	CbGeAlD
Mefloquine—CYP2D6—cerebellum—Parkinson's disease	0.000188	0.00204	CbGeAlD
Mefloquine—ABCB1—midbrain—Parkinson's disease	0.000174	0.0019	CbGeAlD
Mefloquine—ABCB1—spinal cord—Parkinson's disease	0.00017	0.00185	CbGeAlD
Mefloquine—CYP2D6—brain—Parkinson's disease	0.000152	0.00166	CbGeAlD
Mefloquine—ABCB1—head—Parkinson's disease	0.000151	0.00165	CbGeAlD
Mefloquine—ABCB1—nervous system—Parkinson's disease	0.000143	0.00156	CbGeAlD
Mefloquine—ABCB1—central nervous system—Parkinson's disease	0.000138	0.0015	CbGeAlD
Mefloquine—ABCB1—cerebellum—Parkinson's disease	0.000135	0.00147	CbGeAlD
Mefloquine—ABCB1—brain—Parkinson's disease	0.00011	0.00119	CbGeAlD
Mefloquine—ADORA2A—Signaling by NGF—CASP3—Parkinson's disease	3.93e-05	0.000326	CbGpPWpGaD
Mefloquine—ADORA2A—GPCR downstream signaling—ADRBK1—Parkinson's disease	3.92e-05	0.000326	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling Pathways—PENK—Parkinson's disease	3.84e-05	0.000319	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling Pathways—MAG—Parkinson's disease	3.84e-05	0.000319	CbGpPWpGaD
Mefloquine—ABCB1—Integrated Pancreatic Cancer Pathway—ABL1—Parkinson's disease	3.84e-05	0.000318	CbGpPWpGaD
Mefloquine—ABCB1—Allograft Rejection—IL1B—Parkinson's disease	3.83e-05	0.000318	CbGpPWpGaD
Mefloquine—ABCB1—Allograft Rejection—CASP3—Parkinson's disease	3.83e-05	0.000318	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling by GPCR—DRD3—Parkinson's disease	3.82e-05	0.000317	CbGpPWpGaD
Mefloquine—ADORA2A—GPCR downstream signaling—HTR7—Parkinson's disease	3.8e-05	0.000315	CbGpPWpGaD
Mefloquine—ADORA2A—GPCR downstream signaling—DRD2—Parkinson's disease	3.8e-05	0.000315	CbGpPWpGaD
Mefloquine—ABCB1—Integrated Pancreatic Cancer Pathway—BDNF—Parkinson's disease	3.78e-05	0.000314	CbGpPWpGaD
Mefloquine—ADORA1—Signaling Pathways—FGF20—Parkinson's disease	3.71e-05	0.000308	CbGpPWpGaD
Mefloquine—CYP2D6—Biological oxidations—GSTM1—Parkinson's disease	3.7e-05	0.000307	CbGpPWpGaD
Mefloquine—CYP2D6—Metapathway biotransformation—GSTM1—Parkinson's disease	3.65e-05	0.000303	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling by NGF—MAPK8—Parkinson's disease	3.61e-05	0.0003	CbGpPWpGaD
Mefloquine—ADORA1—Signaling Pathways—ADORA2A—Parkinson's disease	3.6e-05	0.000299	CbGpPWpGaD
Mefloquine—ADORA1—Signaling by GPCR—EDN1—Parkinson's disease	3.58e-05	0.000297	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling by GPCR—ADRBK1—Parkinson's disease	3.56e-05	0.000296	CbGpPWpGaD
Mefloquine—ACHE—Metabolism—DDC—Parkinson's disease	3.55e-05	0.000295	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling Pathways—PDYN—Parkinson's disease	3.51e-05	0.000292	CbGpPWpGaD
Mefloquine—CYP3A4—Biological oxidations—CYP2D6—Parkinson's disease	3.49e-05	0.000289	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling by GPCR—HTR7—Parkinson's disease	3.45e-05	0.000286	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling by GPCR—DRD2—Parkinson's disease	3.45e-05	0.000286	CbGpPWpGaD
Mefloquine—ADORA1—GPCR downstream signaling—HTR2A—Parkinson's disease	3.45e-05	0.000286	CbGpPWpGaD
Mefloquine—CYP3A4—Metapathway biotransformation—CYP2D6—Parkinson's disease	3.44e-05	0.000285	CbGpPWpGaD
Mefloquine—ACHE—Metabolism—GSTA4—Parkinson's disease	3.36e-05	0.000279	CbGpPWpGaD
Mefloquine—ABCB1—Integrated Pancreatic Cancer Pathway—FASLG—Parkinson's disease	3.35e-05	0.000278	CbGpPWpGaD
Mefloquine—ADORA1—Signaling Pathways—INSR—Parkinson's disease	3.32e-05	0.000276	CbGpPWpGaD
Mefloquine—ACHE—Metabolism of lipids and lipoproteins—GPX1—Parkinson's disease	3.31e-05	0.000275	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling Pathways—GFAP—Parkinson's disease	3.3e-05	0.000274	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling Pathways—GRM5—Parkinson's disease	3.27e-05	0.000271	CbGpPWpGaD
Mefloquine—CYP19A1—Metabolism—DDC—Parkinson's disease	3.27e-05	0.000271	CbGpPWpGaD
Mefloquine—CYP3A4—Biological oxidations—CYP2E1—Parkinson's disease	3.19e-05	0.000265	CbGpPWpGaD
Mefloquine—BCHE—Metabolism—DDC—Parkinson's disease	3.17e-05	0.000263	CbGpPWpGaD
Mefloquine—ACHE—Metabolism of proteins—IGF2—Parkinson's disease	3.17e-05	0.000263	CbGpPWpGaD
Mefloquine—ACHE—Integrated Pancreatic Cancer Pathway—TNF—Parkinson's disease	3.15e-05	0.000262	CbGpPWpGaD
Mefloquine—CYP3A4—Metapathway biotransformation—CYP2E1—Parkinson's disease	3.15e-05	0.000261	CbGpPWpGaD
Mefloquine—ADORA1—Signaling Pathways—FGB—Parkinson's disease	3.14e-05	0.00026	CbGpPWpGaD
Mefloquine—ADORA1—Signaling by GPCR—HTR2A—Parkinson's disease	3.13e-05	0.00026	CbGpPWpGaD
Mefloquine—ADORA1—Signaling Pathways—HTR1A—Parkinson's disease	3.12e-05	0.000259	CbGpPWpGaD
Mefloquine—CYP19A1—Metabolism—GSTA4—Parkinson's disease	3.08e-05	0.000256	CbGpPWpGaD
Mefloquine—ADORA1—Signaling Pathways—TAC1—Parkinson's disease	3.07e-05	0.000255	CbGpPWpGaD
Mefloquine—ADORA2A—Circadian rythm related genes—IL6—Parkinson's disease	3.06e-05	0.000254	CbGpPWpGaD
Mefloquine—CYP19A1—Metabolism of lipids and lipoproteins—GPX1—Parkinson's disease	3.05e-05	0.000253	CbGpPWpGaD
Mefloquine—ADORA2A—GPCR downstream signaling—EDN1—Parkinson's disease	3.04e-05	0.000253	CbGpPWpGaD
Mefloquine—ACHE—Metabolism—PLA2G6—Parkinson's disease	3.02e-05	0.000251	CbGpPWpGaD
Mefloquine—ADORA1—Signaling Pathways—DRD1—Parkinson's disease	3.02e-05	0.00025	CbGpPWpGaD
Mefloquine—ADORA2A—NGF signalling via TRKA from the plasma membrane—IL6—Parkinson's disease	3e-05	0.000249	CbGpPWpGaD
Mefloquine—BCHE—Metabolism—GSTA4—Parkinson's disease	2.99e-05	0.000249	CbGpPWpGaD
Mefloquine—ACHE—Metabolism—MAOB—Parkinson's disease	2.99e-05	0.000248	CbGpPWpGaD
Mefloquine—BCHE—Metabolism of lipids and lipoproteins—GPX1—Parkinson's disease	2.96e-05	0.000245	CbGpPWpGaD
Mefloquine—ADORA1—Signaling Pathways—DRD3—Parkinson's disease	2.92e-05	0.000242	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling Pathways—FGF20—Parkinson's disease	2.86e-05	0.000238	CbGpPWpGaD
Mefloquine—ACHE—Metabolism of lipids and lipoproteins—APOE—Parkinson's disease	2.85e-05	0.000236	CbGpPWpGaD
Mefloquine—BCHE—Metabolism of proteins—IGF2—Parkinson's disease	2.82e-05	0.000234	CbGpPWpGaD
Mefloquine—ABCB1—Transmembrane transport of small molecules—SLC18A2—Parkinson's disease	2.81e-05	0.000233	CbGpPWpGaD
Mefloquine—ABCB1—Allograft Rejection—TNF—Parkinson's disease	2.78e-05	0.000231	CbGpPWpGaD
Mefloquine—ABCB1—Metabolism—ND3—Parkinson's disease	2.78e-05	0.000231	CbGpPWpGaD
Mefloquine—ABCB1—Metabolism—MCCC1—Parkinson's disease	2.78e-05	0.000231	CbGpPWpGaD
Mefloquine—CYP19A1—Metabolism—PLA2G6—Parkinson's disease	2.78e-05	0.000231	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling by GPCR—EDN1—Parkinson's disease	2.76e-05	0.000229	CbGpPWpGaD
Mefloquine—CYP19A1—Metabolism—MAOB—Parkinson's disease	2.75e-05	0.000228	CbGpPWpGaD
Mefloquine—ADORA1—Signaling Pathways—ADRBK1—Parkinson's disease	2.73e-05	0.000226	CbGpPWpGaD
Mefloquine—BCHE—Metabolism—PLA2G6—Parkinson's disease	2.7e-05	0.000224	CbGpPWpGaD
Mefloquine—BCHE—Metabolism—MAOB—Parkinson's disease	2.67e-05	0.000222	CbGpPWpGaD
Mefloquine—ADORA2A—GPCR downstream signaling—HTR2A—Parkinson's disease	2.66e-05	0.000221	CbGpPWpGaD
Mefloquine—CYP3A4—Biological oxidations—COMT—Parkinson's disease	2.64e-05	0.000219	CbGpPWpGaD
Mefloquine—ADORA1—Signaling Pathways—DRD2—Parkinson's disease	2.64e-05	0.000219	CbGpPWpGaD
Mefloquine—ADORA1—Signaling Pathways—HTR7—Parkinson's disease	2.64e-05	0.000219	CbGpPWpGaD
Mefloquine—CYP3A4—Biological oxidations—GSTP1—Parkinson's disease	2.63e-05	0.000218	CbGpPWpGaD
Mefloquine—CYP3A4—Biological oxidations—MAOA—Parkinson's disease	2.62e-05	0.000218	CbGpPWpGaD
Mefloquine—CYP2D6—Metabolism—MCCC1—Parkinson's disease	2.62e-05	0.000218	CbGpPWpGaD
Mefloquine—CYP2D6—Metabolism—ND3—Parkinson's disease	2.62e-05	0.000218	CbGpPWpGaD
Mefloquine—CYP19A1—Metabolism of lipids and lipoproteins—APOE—Parkinson's disease	2.62e-05	0.000217	CbGpPWpGaD
Mefloquine—ABCB1—Metabolism—TALDO1—Parkinson's disease	2.62e-05	0.000217	CbGpPWpGaD
Mefloquine—ABCB1—Metabolism—OMD—Parkinson's disease	2.62e-05	0.000217	CbGpPWpGaD
Mefloquine—CYP3A4—Metapathway biotransformation—COMT—Parkinson's disease	2.61e-05	0.000216	CbGpPWpGaD
Mefloquine—CYP3A4—Metapathway biotransformation—GSTP1—Parkinson's disease	2.59e-05	0.000215	CbGpPWpGaD
Mefloquine—ABCB1—Transmembrane transport of small molecules—CP—Parkinson's disease	2.58e-05	0.000215	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling Pathways—INSR—Parkinson's disease	2.56e-05	0.000213	CbGpPWpGaD
Mefloquine—BCHE—Metabolism of lipids and lipoproteins—APOE—Parkinson's disease	2.54e-05	0.000211	CbGpPWpGaD
Mefloquine—ABCB1—Metabolism—NDUFB11—Parkinson's disease	2.48e-05	0.000206	CbGpPWpGaD
Mefloquine—CYP2D6—Metabolism—OMD—Parkinson's disease	2.46e-05	0.000205	CbGpPWpGaD
Mefloquine—CYP2D6—Metabolism—TALDO1—Parkinson's disease	2.46e-05	0.000205	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling Pathways—FGB—Parkinson's disease	2.42e-05	0.000201	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling by GPCR—HTR2A—Parkinson's disease	2.42e-05	0.000201	CbGpPWpGaD
Mefloquine—CYP3A4—Biological oxidations—GSTM1—Parkinson's disease	2.42e-05	0.000201	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling Pathways—HTR1A—Parkinson's disease	2.41e-05	0.0002	CbGpPWpGaD
Mefloquine—CYP3A4—Metapathway biotransformation—GSTM1—Parkinson's disease	2.38e-05	0.000198	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling Pathways—TAC1—Parkinson's disease	2.37e-05	0.000197	CbGpPWpGaD
Mefloquine—ABCB1—Metabolism—GCH1—Parkinson's disease	2.37e-05	0.000196	CbGpPWpGaD
Mefloquine—CYP2D6—Metabolism—NDUFB11—Parkinson's disease	2.34e-05	0.000194	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling Pathways—DRD1—Parkinson's disease	2.33e-05	0.000193	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling by NGF—IL6—Parkinson's disease	2.31e-05	0.000191	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling Pathways—DRD3—Parkinson's disease	2.25e-05	0.000187	CbGpPWpGaD
Mefloquine—CYP2D6—Metabolism—GCH1—Parkinson's disease	2.23e-05	0.000185	CbGpPWpGaD
Mefloquine—ACHE—Metabolism—CYP2D6—Parkinson's disease	2.22e-05	0.000185	CbGpPWpGaD
Mefloquine—ADORA1—Signaling Pathways—IGF2—Parkinson's disease	2.21e-05	0.000184	CbGpPWpGaD
Mefloquine—ACHE—Metabolism—CTGF—Parkinson's disease	2.18e-05	0.000181	CbGpPWpGaD
Mefloquine—ADORA1—Signaling Pathways—IGF1R—Parkinson's disease	2.14e-05	0.000178	CbGpPWpGaD
Mefloquine—ADORA1—Signaling Pathways—EDN1—Parkinson's disease	2.11e-05	0.000175	CbGpPWpGaD
Mefloquine—ABCB1—Metabolism—DBH—Parkinson's disease	2.11e-05	0.000175	CbGpPWpGaD
Mefloquine—ABCB1—Metabolism—FBP1—Parkinson's disease	2.11e-05	0.000175	CbGpPWpGaD
Mefloquine—ABCB1—Metabolism—GBA—Parkinson's disease	2.11e-05	0.000175	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling Pathways—ADRBK1—Parkinson's disease	2.11e-05	0.000175	CbGpPWpGaD
Mefloquine—ACHE—Metabolism of proteins—INS—Parkinson's disease	2.1e-05	0.000174	CbGpPWpGaD
Mefloquine—CYP19A1—Metabolism—CYP2D6—Parkinson's disease	2.04e-05	0.00017	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling Pathways—HTR7—Parkinson's disease	2.04e-05	0.000169	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling Pathways—DRD2—Parkinson's disease	2.04e-05	0.000169	CbGpPWpGaD
Mefloquine—ACHE—Metabolism—CYP2E1—Parkinson's disease	2.03e-05	0.000169	CbGpPWpGaD
Mefloquine—ACHE—Metabolism—NQO1—Parkinson's disease	2.01e-05	0.000167	CbGpPWpGaD
Mefloquine—CYP19A1—Metabolism—CTGF—Parkinson's disease	2.01e-05	0.000166	CbGpPWpGaD
Mefloquine—CYP2D6—Metabolism—GBA—Parkinson's disease	1.99e-05	0.000165	CbGpPWpGaD
Mefloquine—CYP2D6—Metabolism—DBH—Parkinson's disease	1.99e-05	0.000165	CbGpPWpGaD
Mefloquine—CYP2D6—Metabolism—FBP1—Parkinson's disease	1.99e-05	0.000165	CbGpPWpGaD
Mefloquine—BCHE—Metabolism—CYP2D6—Parkinson's disease	1.98e-05	0.000165	CbGpPWpGaD
Mefloquine—ACHE—Metabolism—TH—Parkinson's disease	1.98e-05	0.000164	CbGpPWpGaD
Mefloquine—BCHE—Metabolism—CTGF—Parkinson's disease	1.95e-05	0.000162	CbGpPWpGaD
Mefloquine—ADORA1—Signaling Pathways—NGF—Parkinson's disease	1.94e-05	0.000161	CbGpPWpGaD
Mefloquine—ACHE—Metabolism—CYCS—Parkinson's disease	1.9e-05	0.000158	CbGpPWpGaD
Mefloquine—ABCB1—Integrated Pancreatic Cancer Pathway—CASP3—Parkinson's disease	1.89e-05	0.000157	CbGpPWpGaD
Mefloquine—BCHE—Metabolism of proteins—INS—Parkinson's disease	1.88e-05	0.000156	CbGpPWpGaD
Mefloquine—CYP19A1—Metabolism—CYP2E1—Parkinson's disease	1.87e-05	0.000155	CbGpPWpGaD
Mefloquine—ADORA1—Signaling Pathways—HTR2A—Parkinson's disease	1.85e-05	0.000154	CbGpPWpGaD
Mefloquine—CYP19A1—Metabolism—NQO1—Parkinson's disease	1.85e-05	0.000153	CbGpPWpGaD
Mefloquine—ABCB1—Transmembrane transport of small molecules—SLC6A3—Parkinson's disease	1.84e-05	0.000153	CbGpPWpGaD
Mefloquine—CYP19A1—Metabolism—TH—Parkinson's disease	1.82e-05	0.000151	CbGpPWpGaD
Mefloquine—BCHE—Metabolism—CYP2E1—Parkinson's disease	1.81e-05	0.000151	CbGpPWpGaD
Mefloquine—BCHE—Metabolism—NQO1—Parkinson's disease	1.79e-05	0.000149	CbGpPWpGaD
Mefloquine—ABCB1—Transmembrane transport of small molecules—CYCS—Parkinson's disease	1.77e-05	0.000147	CbGpPWpGaD
Mefloquine—BCHE—Metabolism—TH—Parkinson's disease	1.77e-05	0.000147	CbGpPWpGaD
Mefloquine—CYP19A1—Metabolism—CYCS—Parkinson's disease	1.75e-05	0.000145	CbGpPWpGaD
Mefloquine—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK8—Parkinson's disease	1.74e-05	0.000144	CbGpPWpGaD
Mefloquine—ADORA1—Signaling Pathways—APOE—Parkinson's disease	1.72e-05	0.000143	CbGpPWpGaD
Mefloquine—CYP3A4—Metabolism—ND3—Parkinson's disease	1.71e-05	0.000142	CbGpPWpGaD
Mefloquine—CYP3A4—Metabolism—MCCC1—Parkinson's disease	1.71e-05	0.000142	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling Pathways—IGF2—Parkinson's disease	1.71e-05	0.000142	CbGpPWpGaD
Mefloquine—BCHE—Metabolism—CYCS—Parkinson's disease	1.7e-05	0.000141	CbGpPWpGaD
Mefloquine—ACHE—Metabolism—COMT—Parkinson's disease	1.69e-05	0.00014	CbGpPWpGaD
Mefloquine—ACHE—Metabolism—GSTP1—Parkinson's disease	1.68e-05	0.000139	CbGpPWpGaD
Mefloquine—ACHE—Metabolism—MAOA—Parkinson's disease	1.67e-05	0.000139	CbGpPWpGaD
Mefloquine—ACHE—Metabolism—HMOX1—Parkinson's disease	1.65e-05	0.000137	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling Pathways—IGF1R—Parkinson's disease	1.65e-05	0.000137	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling Pathways—EDN1—Parkinson's disease	1.63e-05	0.000135	CbGpPWpGaD
Mefloquine—CYP3A4—Metabolism—TALDO1—Parkinson's disease	1.61e-05	0.000134	CbGpPWpGaD
Mefloquine—CYP3A4—Metabolism—OMD—Parkinson's disease	1.61e-05	0.000134	CbGpPWpGaD
Mefloquine—ACHE—Metabolism—ABCB1—Parkinson's disease	1.59e-05	0.000132	CbGpPWpGaD
Mefloquine—CYP19A1—Metabolism—COMT—Parkinson's disease	1.55e-05	0.000129	CbGpPWpGaD
Mefloquine—ABCB1—Metabolism—DDC—Parkinson's disease	1.55e-05	0.000128	CbGpPWpGaD
Mefloquine—CYP19A1—Metabolism—GSTP1—Parkinson's disease	1.54e-05	0.000128	CbGpPWpGaD
Mefloquine—ACHE—Metabolism—GSTM1—Parkinson's disease	1.54e-05	0.000128	CbGpPWpGaD
Mefloquine—CYP19A1—Metabolism—MAOA—Parkinson's disease	1.54e-05	0.000128	CbGpPWpGaD
Mefloquine—ABCB1—Transmembrane transport of small molecules—HMOX1—Parkinson's disease	1.54e-05	0.000128	CbGpPWpGaD
Mefloquine—CYP3A4—Metabolism—NDUFB11—Parkinson's disease	1.53e-05	0.000127	CbGpPWpGaD
Mefloquine—CYP19A1—Metabolism—HMOX1—Parkinson's disease	1.52e-05	0.000126	CbGpPWpGaD
Mefloquine—BCHE—Metabolism—COMT—Parkinson's disease	1.5e-05	0.000125	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling Pathways—NGF—Parkinson's disease	1.5e-05	0.000124	CbGpPWpGaD
Mefloquine—BCHE—Metabolism—GSTP1—Parkinson's disease	1.5e-05	0.000124	CbGpPWpGaD
Mefloquine—BCHE—Metabolism—MAOA—Parkinson's disease	1.49e-05	0.000124	CbGpPWpGaD
Mefloquine—ACHE—Metabolism—GPX1—Parkinson's disease	1.48e-05	0.000122	CbGpPWpGaD
Mefloquine—BCHE—Metabolism—HMOX1—Parkinson's disease	1.48e-05	0.000122	CbGpPWpGaD
Mefloquine—ADORA1—Signaling Pathways—INS—Parkinson's disease	1.47e-05	0.000122	CbGpPWpGaD
Mefloquine—ABCB1—Metabolism—GSTA4—Parkinson's disease	1.46e-05	0.000121	CbGpPWpGaD
Mefloquine—CYP19A1—Metabolism—ABCB1—Parkinson's disease	1.46e-05	0.000121	CbGpPWpGaD
Mefloquine—CYP2D6—Metabolism—DDC—Parkinson's disease	1.46e-05	0.000121	CbGpPWpGaD
Mefloquine—CYP3A4—Metabolism—GCH1—Parkinson's disease	1.46e-05	0.000121	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling Pathways—HTR2A—Parkinson's disease	1.43e-05	0.000119	CbGpPWpGaD
Mefloquine—CYP19A1—Metabolism—GSTM1—Parkinson's disease	1.42e-05	0.000118	CbGpPWpGaD
Mefloquine—BCHE—Metabolism—ABCB1—Parkinson's disease	1.42e-05	0.000118	CbGpPWpGaD
Mefloquine—CYP2D6—Metabolism—GSTA4—Parkinson's disease	1.38e-05	0.000114	CbGpPWpGaD
Mefloquine—BCHE—Metabolism—GSTM1—Parkinson's disease	1.38e-05	0.000114	CbGpPWpGaD
Mefloquine—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—Parkinson's disease	1.37e-05	0.000114	CbGpPWpGaD
Mefloquine—ACHE—Metabolism—MTHFR—Parkinson's disease	1.36e-05	0.000113	CbGpPWpGaD
Mefloquine—CYP19A1—Metabolism—GPX1—Parkinson's disease	1.36e-05	0.000113	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling Pathways—APOE—Parkinson's disease	1.33e-05	0.00011	CbGpPWpGaD
Mefloquine—BCHE—Metabolism—GPX1—Parkinson's disease	1.32e-05	0.000109	CbGpPWpGaD
Mefloquine—ABCB1—Metabolism—PLA2G6—Parkinson's disease	1.32e-05	0.000109	CbGpPWpGaD
Mefloquine—ABCB1—Metabolism—MAOB—Parkinson's disease	1.3e-05	0.000108	CbGpPWpGaD
Mefloquine—CYP3A4—Metabolism—FBP1—Parkinson's disease	1.3e-05	0.000108	CbGpPWpGaD
Mefloquine—CYP3A4—Metabolism—DBH—Parkinson's disease	1.3e-05	0.000108	CbGpPWpGaD
Mefloquine—CYP3A4—Metabolism—GBA—Parkinson's disease	1.3e-05	0.000108	CbGpPWpGaD
Mefloquine—ACHE—Metabolism—APOE—Parkinson's disease	1.27e-05	0.000105	CbGpPWpGaD
Mefloquine—CYP19A1—Metabolism—MTHFR—Parkinson's disease	1.25e-05	0.000104	CbGpPWpGaD
Mefloquine—CYP2D6—Metabolism—PLA2G6—Parkinson's disease	1.24e-05	0.000103	CbGpPWpGaD
Mefloquine—CYP2D6—Metabolism—MAOB—Parkinson's disease	1.23e-05	0.000102	CbGpPWpGaD
Mefloquine—BCHE—Metabolism—MTHFR—Parkinson's disease	1.22e-05	0.000101	CbGpPWpGaD
Mefloquine—CYP19A1—Metabolism—APOE—Parkinson's disease	1.17e-05	9.67e-05	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling Pathways—INS—Parkinson's disease	1.13e-05	9.41e-05	CbGpPWpGaD
Mefloquine—BCHE—Metabolism—APOE—Parkinson's disease	1.13e-05	9.39e-05	CbGpPWpGaD
Mefloquine—ADORA1—Signaling Pathways—CASP3—Parkinson's disease	1.09e-05	9.08e-05	CbGpPWpGaD
Mefloquine—ADORA1—Signaling by GPCR—IL6—Parkinson's disease	1.09e-05	9.02e-05	CbGpPWpGaD
Mefloquine—ACHE—Metabolism—INS—Parkinson's disease	1.08e-05	8.99e-05	CbGpPWpGaD
Mefloquine—ADORA1—Signaling Pathways—MAPK8—Parkinson's disease	1.01e-05	8.34e-05	CbGpPWpGaD
Mefloquine—CYP19A1—Metabolism—INS—Parkinson's disease	9.96e-06	8.26e-05	CbGpPWpGaD
Mefloquine—ABCB1—Metabolism—CYP2D6—Parkinson's disease	9.68e-06	8.03e-05	CbGpPWpGaD
Mefloquine—BCHE—Metabolism—INS—Parkinson's disease	9.66e-06	8.02e-05	CbGpPWpGaD
Mefloquine—CYP3A4—Metabolism—DDC—Parkinson's disease	9.53e-06	7.91e-05	CbGpPWpGaD
Mefloquine—ABCB1—Metabolism—CTGF—Parkinson's disease	9.5e-06	7.88e-05	CbGpPWpGaD
Mefloquine—CYP3A4—Metabolism—GSTA4—Parkinson's disease	9e-06	7.47e-05	CbGpPWpGaD
Mefloquine—CYP2D6—Metabolism—CTGF—Parkinson's disease	8.95e-06	7.43e-05	CbGpPWpGaD
Mefloquine—ABCB1—Metabolism—CYP2E1—Parkinson's disease	8.85e-06	7.35e-05	CbGpPWpGaD
Mefloquine—ABCB1—Metabolism—NQO1—Parkinson's disease	8.75e-06	7.26e-05	CbGpPWpGaD
Mefloquine—ABCB1—Metabolism—TH—Parkinson's disease	8.63e-06	7.16e-05	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling Pathways—CASP3—Parkinson's disease	8.44e-06	7.01e-05	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling by GPCR—IL6—Parkinson's disease	8.39e-06	6.96e-05	CbGpPWpGaD
Mefloquine—CYP2D6—Metabolism—CYP2E1—Parkinson's disease	8.34e-06	6.92e-05	CbGpPWpGaD
Mefloquine—ABCB1—Metabolism—CYCS—Parkinson's disease	8.28e-06	6.87e-05	CbGpPWpGaD
Mefloquine—CYP2D6—Metabolism—NQO1—Parkinson's disease	8.25e-06	6.85e-05	CbGpPWpGaD
Mefloquine—CYP2D6—Metabolism—TH—Parkinson's disease	8.13e-06	6.75e-05	CbGpPWpGaD
Mefloquine—CYP3A4—Metabolism—PLA2G6—Parkinson's disease	8.11e-06	6.73e-05	CbGpPWpGaD
Mefloquine—CYP3A4—Metabolism—MAOB—Parkinson's disease	8.02e-06	6.66e-05	CbGpPWpGaD
Mefloquine—CYP2D6—Metabolism—CYCS—Parkinson's disease	7.81e-06	6.48e-05	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling Pathways—MAPK8—Parkinson's disease	7.76e-06	6.44e-05	CbGpPWpGaD
Mefloquine—ABCB1—Metabolism—COMT—Parkinson's disease	7.34e-06	6.09e-05	CbGpPWpGaD
Mefloquine—ABCB1—Metabolism—GSTP1—Parkinson's disease	7.3e-06	6.06e-05	CbGpPWpGaD
Mefloquine—ABCB1—Metabolism—MAOA—Parkinson's disease	7.28e-06	6.04e-05	CbGpPWpGaD
Mefloquine—ABCB1—Metabolism—HMOX1—Parkinson's disease	7.2e-06	5.98e-05	CbGpPWpGaD
Mefloquine—CYP2D6—Metabolism—COMT—Parkinson's disease	6.91e-06	5.74e-05	CbGpPWpGaD
Mefloquine—CYP2D6—Metabolism—GSTP1—Parkinson's disease	6.88e-06	5.71e-05	CbGpPWpGaD
Mefloquine—CYP2D6—Metabolism—MAOA—Parkinson's disease	6.86e-06	5.7e-05	CbGpPWpGaD
Mefloquine—CYP2D6—Metabolism—HMOX1—Parkinson's disease	6.78e-06	5.63e-05	CbGpPWpGaD
Mefloquine—ABCB1—Metabolism—GSTM1—Parkinson's disease	6.71e-06	5.57e-05	CbGpPWpGaD
Mefloquine—CYP2D6—Metabolism—ABCB1—Parkinson's disease	6.51e-06	5.4e-05	CbGpPWpGaD
Mefloquine—ABCB1—Metabolism—GPX1—Parkinson's disease	6.42e-06	5.33e-05	CbGpPWpGaD
Mefloquine—ADORA1—Signaling Pathways—IL6—Parkinson's disease	6.42e-06	5.33e-05	CbGpPWpGaD
Mefloquine—CYP2D6—Metabolism—GSTM1—Parkinson's disease	6.32e-06	5.25e-05	CbGpPWpGaD
Mefloquine—CYP2D6—Metabolism—GPX1—Parkinson's disease	6.05e-06	5.02e-05	CbGpPWpGaD
Mefloquine—CYP3A4—Metabolism—CYP2D6—Parkinson's disease	5.96e-06	4.95e-05	CbGpPWpGaD
Mefloquine—ABCB1—Metabolism—MTHFR—Parkinson's disease	5.93e-06	4.92e-05	CbGpPWpGaD
Mefloquine—CYP3A4—Metabolism—CTGF—Parkinson's disease	5.85e-06	4.86e-05	CbGpPWpGaD
Mefloquine—CYP2D6—Metabolism—MTHFR—Parkinson's disease	5.59e-06	4.64e-05	CbGpPWpGaD
Mefloquine—ABCB1—Metabolism—APOE—Parkinson's disease	5.52e-06	4.58e-05	CbGpPWpGaD
Mefloquine—CYP3A4—Metabolism—CYP2E1—Parkinson's disease	5.45e-06	4.53e-05	CbGpPWpGaD
Mefloquine—CYP3A4—Metabolism—NQO1—Parkinson's disease	5.39e-06	4.48e-05	CbGpPWpGaD
Mefloquine—CYP3A4—Metabolism—TH—Parkinson's disease	5.32e-06	4.41e-05	CbGpPWpGaD
Mefloquine—CYP2D6—Metabolism—APOE—Parkinson's disease	5.2e-06	4.32e-05	CbGpPWpGaD
Mefloquine—CYP3A4—Metabolism—CYCS—Parkinson's disease	5.1e-06	4.24e-05	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling Pathways—IL6—Parkinson's disease	4.96e-06	4.11e-05	CbGpPWpGaD
Mefloquine—ABCB1—Metabolism—INS—Parkinson's disease	4.72e-06	3.91e-05	CbGpPWpGaD
Mefloquine—CYP3A4—Metabolism—COMT—Parkinson's disease	4.52e-06	3.75e-05	CbGpPWpGaD
Mefloquine—CYP3A4—Metabolism—GSTP1—Parkinson's disease	4.5e-06	3.73e-05	CbGpPWpGaD
Mefloquine—CYP3A4—Metabolism—MAOA—Parkinson's disease	4.49e-06	3.72e-05	CbGpPWpGaD
Mefloquine—CYP2D6—Metabolism—INS—Parkinson's disease	4.44e-06	3.69e-05	CbGpPWpGaD
Mefloquine—CYP3A4—Metabolism—HMOX1—Parkinson's disease	4.44e-06	3.68e-05	CbGpPWpGaD
Mefloquine—CYP3A4—Metabolism—ABCB1—Parkinson's disease	4.26e-06	3.53e-05	CbGpPWpGaD
Mefloquine—CYP3A4—Metabolism—GSTM1—Parkinson's disease	4.13e-06	3.43e-05	CbGpPWpGaD
Mefloquine—CYP3A4—Metabolism—GPX1—Parkinson's disease	3.96e-06	3.29e-05	CbGpPWpGaD
Mefloquine—CYP3A4—Metabolism—MTHFR—Parkinson's disease	3.65e-06	3.03e-05	CbGpPWpGaD
Mefloquine—CYP3A4—Metabolism—APOE—Parkinson's disease	3.4e-06	2.82e-05	CbGpPWpGaD
Mefloquine—CYP3A4—Metabolism—INS—Parkinson's disease	2.91e-06	2.41e-05	CbGpPWpGaD
